Pharmacotherapy of borderline personality disorder
- PMID: 9418746
Pharmacotherapy of borderline personality disorder
Abstract
Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.
Similar articles
-
The use of newer antidepressants for panic disorder.J Clin Psychiatry. 1997;58 Suppl 14:54-8; discussion 59. J Clin Psychiatry. 1997. PMID: 9418747 Review.
-
Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.J Clin Psychiatry. 1998;59 Suppl 1:30-5; discussion 36-7. J Clin Psychiatry. 1998. PMID: 9448667 Review.
-
Pharmacotherapy of borderline disorders.Compr Psychiatry. 1981 Nov-Dec;22(6):535-43. doi: 10.1016/0010-440x(81)90001-8. Compr Psychiatry. 1981. PMID: 6118234 No abstract available.
-
Is there any drug treatment of choice for the borderline patient?Acta Psychiatr Scand Suppl. 1994;379:50-5. doi: 10.1111/j.1600-0447.1994.tb05818.x. Acta Psychiatr Scand Suppl. 1994. PMID: 8010152 Review.
-
Antidepressants.J Clin Psychiatry. 1997;58 Suppl 6:9-25. J Clin Psychiatry. 1997. PMID: 9227669 Review. No abstract available.